|
|
|
|
|
enzyme inhibitors (D-glucose analogue), substrate reduction therapy |
|
|
|
|
|
estrogen agonists/antagonists |
|
|
|
estrogens, progestins |
|
farnesoid X receptor agonists |
|
|
|
fenamate, nonsteroidal anti-inflammatory drugs (NSAIDs) |
|
|
|
|
|
|
|
|
|
|
|
five ht4 agonists |
|
|
|
folate antagonists, sulfonamides |
|
|
|
fourth.generation.cephalosporins |
|
|
|
fusion proteins, interleukin antagonists |
|
|
|
gi protectants |
|
glucosylceramide synthase inhibitors |
|
|
|
glycylcyclines |
|
|
|
|
